Tharimmune Inc.(THAR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

THAR Tharimmune Inc.

Pre-Mkt 12-23 06:11:53 EST

2.49

+0.17

+7.33%

High2.58	Low2.37	Vol723.35K
Open2.54	D1 Closing2.32	Amplitude9.05%
Mkt Cap87.26M	Tradable Cap81.36M	Total Shares35.04M
T/O1.82M	T/O Rate2.21%	Tradable Shares32.68M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"THAR","market":"US","secType":"STK","nameCN":"Tharimmune Inc.","latestPrice":2.49,"timestamp":1766437200000,"preClose":2.32,"halted":0,"volume":723349,"delay":0,"floatShares":32676000,"shares":35044800,"eps":-9.409598,"marketStatus":"Pre-Mkt","change":0.17,"latestTime":"12-23 06:11:53 EST","open":2.54,"high":2.5799,"low":2.37,"amount":1822679.619871,"amplitude":0.090474,"askPrice":2.8,"askSize":100,"bidPrice":2.45,"bidSize":55,"shortable":3,"etf":0,"ttmEps":-9.409598,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766500200000},"marketStatusCode":1,"adr":0,"listingDate":1641963600000,"exchange":"NASDAQ","adjPreClose":2.49,"postHourTrading":{"tag":"盘后","latestPrice":2.5424,"preClose":2.49,"latestTime":"19:59 EST","volume":9363,"amount":23393.8247,"timestamp":1766451577604},"volumeRatio":1.0821925926080243},"requestUrl":"/m/hq/s/THAR","defaultTab":"news","newsList":[{"id":"2592906234","title":"Tharimmune Raises $545 Million in Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2592906234","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592906234?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:15","pubTimestamp":1766063725,"startTime":"0","endTime":"0","summary":"Tharimmune Inc. established its digital asset treasury strategy in November 2025 with a $545 million private placement. The proceeds from this unregistered sale of shares are intended to support the expansion and long-term ecosystem development of the Canton Network, including the acquisition of Canton Coin and deeper integration within the network's infrastructure.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via PR Newswire  on December 18, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL3xqbzT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2592493709","title":"Tharimmune Inc. Announces Date for Upcoming Special Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2592493709","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592493709?lang=en_us&edition=fundamental","pubTime":"2025-12-17 05:21","pubTimestamp":1765920087,"startTime":"0","endTime":"0","summary":"Tharimmune, Inc. has announced that it will hold a special meeting of stockholders on January 22, 2026. During the meeting, stockholders will be asked to vote on several proposals, including the election of two new directors to the Board, the approval of the issuance of shares of common stock upon the exercise of Strategic Advisor Warrants, the approval of the issuance of shares of common stock upon the exercise of Cryptocurrency Pre-Funded Warrants, an amendment to the 2023 Equity Incentive Plan, and the potential adjournment of the special meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL4d42W3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","THAR"],"gpt_icon":0},{"id":"2590097955","title":"Tharimmune Inc. Appoints Jacob Asbury as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2590097955","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590097955?lang=en_us&edition=fundamental","pubTime":"2025-12-12 21:15","pubTimestamp":1765545333,"startTime":"0","endTime":"0","summary":"Tharimmune Inc. has appointed Jacob Asbury as Chief Financial Officer. Asbury will oversee financial strategy and operations, including capital planning, treasury management, and the development of the company's digital asset treasury infrastructure. He joins Tharimmune with extensive experience in capital markets and fintech, having previously served as CFO of Clear Street Group and held similar roles at other firms.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via Business Wire  on December 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDLbT8J0l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2584993921","title":"Tharimmune Appoints Sireesh Appajosyula As Interim CFO On Nov 7 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2584993921","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584993921?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:15","pubTimestamp":1763572557,"startTime":"0","endTime":"0","summary":"Nov 11 (Reuters) - Tharimmune Inc ::*THARIMMUNE INC - ON NOV 7, APPOINTS SIREESH APPAJOSYULA AS INTERIM CFO - SEC FILING  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 10-NOV-202522:44:16 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD1zQwny:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","THAR"],"gpt_icon":0},{"id":"2583686460","title":"Tharimmune Inc. Files Initial Statement of Beneficial Ownership for President Mark Toomey","url":"https://stock-news.laohu8.com/highlight/detail?id=2583686460","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583686460?lang=en_us&edition=fundamental","pubTime":"2025-11-15 03:19","pubTimestamp":1763147950,"startTime":"0","endTime":"0","summary":"Tharimmune Inc. has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing names Mark Christopher Toomey as the beneficial owner, who serves as President of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL1DFMJl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","THAR"],"gpt_icon":0},{"id":"2583515940","title":"BUZZ-U.S. STOCKS ON THE MOVE-Broadwind, Verizon, APA","url":"https://stock-news.laohu8.com/highlight/detail?id=2583515940","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583515940?lang=en_us&edition=fundamental","pubTime":"2025-11-14 03:09","pubTimestamp":1763060958,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Broadwind, Verizon, APAEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL6N3WP0NC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTRI","HAL","NEM","SPB","SSYS","SG","CDE","PSFE","BR","ANNX","IONS","HZO","ALB","CLBT","AMAT","IMRX","IE0009355771.USD","MRSN","XNET","LU0234572021.USD","ARDT","MRK","SBH","SCVL","LU2458330243.SGD","KURA","FLY","DDS","THAR","VZ","BTDR","APA","DASH","HL","SLB","EPC","MGRX","CVX","SEE","BWEN","CTEV"],"gpt_icon":1},{"id":"2583596288","title":"Tharimmune Shares Drop Premarket Following FDA Feedback on Plan for Lead Clinical Asset","url":"https://stock-news.laohu8.com/highlight/detail?id=2583596288","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583596288?lang=en_us&edition=fundamental","pubTime":"2025-11-13 22:23","pubTimestamp":1763043780,"startTime":"0","endTime":"0","summary":"Tharimmune's shares were under pressure Thursday despite the company's lead clinical asset receiving what it said was positive feedback from the Food and Drug Administration on a simulation modeling plan.In premarket trading, the shares were down 6% after climbing sharply earlier in the morning. The stock has climbed almost 60% this year, last closing at $3.22.Tharimmune said the FDA following a review concurred with its proposed modeling plan for its TH104 nalmefene buccal film opioid treatment, and provided guidance on specific technical elements that the company plans to integrate into the finalized modeling.It said the FDA's feedback further de-risks the TH104 program.Tharimmune said it presented its initial pharmacokinetic simulation results and a plan for a more detailed pharmacokinetic modeling for FDA review. The modeling plan represents a critical component in advancing TH104 as a prophylactic countermeasure to mitigate respiratory depression caused by fentanyl and other ultra","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2583459369","title":"BUZZ-Tharimmune rises after US FDA backs opioid overdose prevention drug plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2583459369","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583459369?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:38","pubTimestamp":1763041093,"startTime":"0","endTime":"0","summary":"BUZZ-Tharimmune rises after US FDA backs opioid overdose prevention drug plan** Shares of drug-developer Tharimmune THAR.O rise 1.58% to $3.24 premarket** Co says it receives positive feedback from the U.S. FDA for its experimental drug TH104, designed to prevent breathing problems caused by fentanyl and other powerful opioids** The FDA agrees with co's plan to use computer modeling to show how the drug works in the body and offers technical advice to improve the study - THAR** Co's TH104 is a thin film that dissolves in the mouth, designed for easy use by first responders or military personnel exposed to dangerous opioids - THAR** Co simulations show TH104 starts working in 30 min and protects for 24 hrs vs naloxone's <2 hrs** Up to last close, stock up ~59% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nL4N3WP0ZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","THAR"],"gpt_icon":0},{"id":"2583598265","title":"Tharimmune’s TH104 receives positive feedback from FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2583598265","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583598265?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:10","pubTimestamp":1763039459,"startTime":"0","endTime":"0","summary":"Tharimmune (THAR) announced an update from the biotechnology side of the business. Its lead clinical asset, TH104, received positive feedback from ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tharimmunes-th104-receives-positive-feedback-from-fda-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tharimmunes-th104-receives-positive-feedback-from-fda-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2583871598","title":"Tharimmune Receives Positive FDA Feedback for TH104 Prophylaxis Program Against Respiratory Depression From Fentanyl and Ultrapotent Opioids","url":"https://stock-news.laohu8.com/highlight/detail?id=2583871598","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583871598?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:05","pubTimestamp":1763039100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nTUA46YXYY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","THAR"],"gpt_icon":0},{"id":"2582491386","title":"BRIEF-Tharimmune Appoints Sireesh Appajosyula As Interim CFO On Nov 7 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2582491386","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582491386?lang=en_us&edition=fundamental","pubTime":"2025-11-11 06:44","pubTimestamp":1762814656,"startTime":"0","endTime":"0","summary":"BRIEF-Tharimmune Appoints Sireesh Appajosyula As Interim CFO On Nov 7 - SEC FilingNov 11  - Tharimmune Inc THAR.O:THARIMMUNE INC - ON NOV 7, APPOINTS SIREESH APPAJOSYULA AS INTERIM CFO - SEC FILINGSource text: [ID:n0001493152-25-021577]Further company coverage: THAR.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nFWN3WM21L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2582386664","title":"Tharimmune Inc - on Nov 7, Appoints Sireesh Appajosyula as Interim CFO - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2582386664","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582386664?lang=en_us&edition=fundamental","pubTime":"2025-11-11 06:36","pubTimestamp":1762814193,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nFWN3WM21L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2582438655","title":"Tharimmune Appoints Sireesh Appajosyula as Interim CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2582438655","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582438655?lang=en_us&edition=fundamental","pubTime":"2025-11-11 06:31","pubTimestamp":1762813903,"startTime":"0","endTime":"0","summary":"Tharimmune Inc. has announced the appointment of Sireesh Appajosyula as interim Chief Financial Officer. His term will run until December 31, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 10, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL8btm5Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","THAR"],"gpt_icon":0},{"id":"2581001206","title":"BRIEF-Tharimmune Entered ATM Sales Agreement Worth Up To $64.9 Million - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2581001206","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581001206?lang=en_us&edition=fundamental","pubTime":"2025-11-07 19:28","pubTimestamp":1762514900,"startTime":"0","endTime":"0","summary":"BRIEF-Tharimmune Entered ATM Sales Agreement Worth Up To $64.9 Million - SEC FilingNov 7  - Tharimmune Inc THAR.O:THARIMMUNE INC - ON NOV 6, ENTERED ATM SALES AGREEMENT WORTH UP TO $64.9 MILLION - SEC FILINGSource text: [ID:n0001493152-25-021152]Further company coverage: THAR.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nFWN3WJ0FL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2581001696","title":"Tharimmune Inc - on Nov 6, Entered Atm Sales Agreement Worth up to $64.9 Mln - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2581001696","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581001696?lang=en_us&edition=fundamental","pubTime":"2025-11-07 19:17","pubTimestamp":1762514241,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nFWN3WJ0FL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2581804892","title":"Press Release: Tharimmune, Inc. Closes $545 Million Private Placement to Establish Canton Coin Treasury Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2581804892","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581804892?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:16","pubTimestamp":1762463760,"startTime":"0","endTime":"0","summary":"Led by DRW and Liberty City Ventures, Transaction Cements Tharimmune as First Public Company to Deliver Canton-Aligned DAT Strategy. Net Proceeds Support Acquisition of Canton Coin and Active Network Participation via Validator Infrastructure and Application Development. NEW YORK, Nov. 6, 2025 /PRNewswire/ -- Tharimmune, Inc.  , a publicly traded company that will leverage the Canton Coin  to support the Canton Network's ability to digitize traditional financial markets, today announced the successful close of its previously announced private placement for the purchase and sale of shares of common stock  at a price of $3.075 per share, resulting in aggregate gross proceeds of approximately $545 million, before deducting placement agent fees and other offering expenses .Tharimmune intends to use the net proceeds to acquire CC, the utility token supporting interoperability and settlement across the Canton Network, and to support the Company's plans to operate as a Super Validator and run","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TLTW","US3Y.BOND","US12M.BOND","US6M.BOND","US30Y.BOND","US7Y.BOND","THAR","US5Y.BOND","US10Y.BOND","TMF","US2Y.BOND"],"gpt_icon":1},{"id":"2580444752","title":"Gold Edges Higher; ISM Manufacturing PMI Falls In October","url":"https://stock-news.laohu8.com/highlight/detail?id=2580444752","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580444752?lang=en_us&edition=fundamental","pubTime":"2025-11-04 03:23","pubTimestamp":1762197825,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/11/48602067/gold-edges-higher-ism-manufacturing-pmi-falls-in-october","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","QURE","LU0994945656.USD","LU1023059063.AUD","TSYW.SI","ALVO","LU0390134368.USD","LU1066051811.HKD",".IXIC","IE00BBT3K403.USD","LU1221951046.USD","QLD","BK4581","SQQQ","PSQ","LU0889566641.SGD","LU2430703251.USD","TQQQ","CRL","LU2112291526.USD","LU0058720904.USD","USJW.SI","LU0912757837.SGD","ALPS","LU2347655156.SGD","PMI","LU1430594728.SGD","LU1506573853.SGD","RHLD","IE00BFMHRM44.USD","LU0792757196.USD","LU0640476718.USD","LU1221951129.SGD","QID","CIFR","LU1066051498.USD","IE00B19Z3B42.SGD","NVIW.SI","JNJ","BK4530","LU1674673691.USD","LU0234572021.USD","SG9999002232.USD","THAR","IE000M9KFDE8.USD","MNQmain","USAW.SI","LU1196500208.SGD","NQmain"],"gpt_icon":1},{"id":"2580221972","title":"Tharimmune announces $540M private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2580221972","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580221972?lang=en_us&edition=fundamental","pubTime":"2025-11-03 22:11","pubTimestamp":1762179071,"startTime":"0","endTime":"0","summary":"Tharimmune (THAR) announced that it has entered into subscription agreements with certain institutional and accredited investors in a private place...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tharimmune-announces-540m-private-placement-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tharimmune-announces-540m-private-placement-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2580219614","title":"Tharimmune Raises $540 Million in Private Placement Led by DRW and Liberty City Ventures","url":"https://stock-news.laohu8.com/highlight/detail?id=2580219614","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580219614?lang=en_us&edition=fundamental","pubTime":"2025-11-03 22:05","pubTimestamp":1762178720,"startTime":"0","endTime":"0","summary":"Tharimmune Inc.  has announced a private placement of approximately $540 million, led by DRW and Liberty City Ventures. The offering involves the sale of common stock or pre-funded warrants to institutional and accredited investors at $3.075 per share. Other notable participants include ARK Invest, Kraken, Polychain Capital, and the Canton Foundation, among others. The company plans to use the proceeds to implement a next-generation DAT strategy aligned with a vehicle designed for institutional blockchain adoption. Clear Street acted as the sole placement agent and financial advisor for the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via PR ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDL77DqNQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THAR","BK4139"],"gpt_icon":0},{"id":"2580821962","title":"Tharimmune Inc - Mark Wendland Appointed CEO, Mark Toomey Appointed President","url":"https://stock-news.laohu8.com/highlight/detail?id=2580821962","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580821962?lang=en_us&edition=fundamental","pubTime":"2025-11-03 22:04","pubTimestamp":1762178697,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nTUA9TQP5J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["THAR","BK4139"],"gpt_icon":0}],"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tharimmune Inc.(THAR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Tharimmune Inc.(THAR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Tharimmune Inc.,THAR,Tharimmune Inc.股票,Tharimmune Inc.股票老虎,Tharimmune Inc.股票老虎国际,Tharimmune Inc.行情,Tharimmune Inc.股票行情,Tharimmune Inc.股价,Tharimmune Inc.股市,Tharimmune Inc.股票价格,Tharimmune Inc.股票交易,Tharimmune Inc.股票购买,Tharimmune Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tharimmune Inc.(THAR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Tharimmune Inc.(THAR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}